BIBCL
BHARAT IMMUNOLOGICALS & BIOLOGHealthcare
LTP
16.07
CHG · %
+0.15 (+0.94%)
VOL · TODAY
17.15K
PREV CLOSE
15.92
Today's range15.85 · 16.45
16.07
52-week range15.85 · 35.88
16.07
Loading candles…
Bharat Immunological and Biologicals Corporation, incorporated in 1989, is a Central Public Sector Undertaking under the Department of Biotechnology, Ministry of Science and Technology, Government of India. Operating within the biotechnology and pharmaceutical industries, the company focuses on the manufacture of vaccines and biological products including Oral Polio Vaccine, Zinc Tablets, Diarrhea Management Kits, and BIB Sweet Tablets. Its operations are based in India, where it contributes to the national immunization program through the production of Oral Polio Vaccines. As a government-owned enterprise, it aims to achieve self-sufficiency in producing high-quality vaccines and biologicals for public health initiatives. No information on founders, key management, subsidiaries, or stock exchange listings is provided.
BIBCL is not part of any active scan today.
This page is a live market overview for BHARAT IMMUNOLOGICALS & BIOLOG (BIBCL) on the BSE. As a listed security, BHARAT IMMUNOLOGICALS & BIOLOG is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BIBCL before placing trades on tick2trade.
As of the latest feed, BIBCL last traded at ₹16.07 on BSE, up ₹0.15 (0.94%) from the previous close of ₹15.92. Today's session range is ₹15.85 – ₹16.45, against a 52-week band of ₹15.85 – ₹35.88. Traded volume today stands at 17.15K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for BIBCL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BIBCL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BHARAT IMMUNOLOGICALS & BIOLOG before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BIBCL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BIBCL option chain page linked from this overview.
// similar in healthcare314 total